1 / 7

Daily equity reports 15 oct 2018

CapitalStars Award Winning,SEBI registered investment advisory company.We provide intraday &amp; positional services in equity,derivative ,commodity &amp; currency.<br>http://www.capitalstars.com/<br>

PeehuSharma
Télécharger la présentation

Daily equity reports 15 oct 2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 15TH OCTOBER 2018 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! 34733.58 INDIANEQUITYBENCHMARK:- At the close of market hours, the Sensex closed up 461.42 points or 1.35% at 10472.50 34760.89, while the Nifty rose 159.10 points or 1.54% at ASIAN MARKET 10460.10. The market breadth was positive as 2,031 shares CLOSE PREVIOUS advanced, against a decline of 610 shares, while 759 shares NIKKEI 22694.66 were unchanged.Axis Bank, State Bank of India, Bajaj Finance 25801.49 and Bajaj Finserv were the top gainers, while Infosys, TCS, and 2129.67 Bharti Infratel lost the most. GLOBALFACE SECTORIAL INDICES CLOSE CHANGE (%) ! 10671.30 2.29 Asian Market - Asian markets finished higher today with sharesinChinaleadingtheregion.TheShanghaiCompositeis up 0.18% whileJapan'sNikkei 225 is up 0.16%andHong Kong'sHangSengisup0.08%. 2.35 2.86 ! 2.36 U.S.Market-RonPaul:USisbarrelingtowardastockmarket dropof50%ormore,andthere'snowaytopreventit. 25395.85 2.47 ! Europeanmarkets- European markets are lower today with shares in France off the most. The CAC 40 is down 0.55% while Germany's DAX CLOSE CHANGE (%) is off 0.48% and London's FTSE 100 is lower by 0.08%. MARUTI 7303.00 6.22 2286.00 5.73 5.56 M&M 5.25 TOP LOSERS CLOSE CHANGE (%) 1911.45 -3.46 -1.87 WIPRO -0.26 TITAN -0.20 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE STRATEGY SCRIPT CLOSE (%) 10.43 TATA PIVOT POINTS P 10420 R1 R2 10584 RESISTANCE R1-10580 R2-10740 R3 10748 7.47 EICHER MOT 10092 10256 10358 10522 6.78 AMBUJA CEM SUPPORT S1-10350 S2-10250 7283.05 MARUTI CLOSE (%) -2.92 -2.38 INFY 2043.05 -2.27 TCS HCLTECH 1046.15 -1.90 BULLISH PIVOT POINTS P 25085 S3 S1 24809 R1 25584 R2 R3 NET 23535 24310 (CR.) RESISTANCE BANK NIFTY 4610.61 DII 3956.84 NSE TOTALS ADVANCE 8 BANK NIFTY 0 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! RBItopumpRs12KcrinmarketsonOct11! IndiabullsHousingFinanceraises homeloansratesby20bps IndiabullsHousingFinanceLtd.(IBHFL),thecountry’s secondlargesthousingfinancecompany,announcedan increaseininterestratesonhomeloansby20bps.The increaseinlendingratesreflectstheriseinthecostof funds.The rate of interest on new home loans for womenapplicants/co-applicantsis8.80%forloansof up-to 35lakhs and 8.95% onwards for loans above 35lakhs. Theinterest rates would be 5bps higherfor non-womenapplicants. tomanageliquidity TheReserveBankofIndia(RBI)hasannouncedthatitwill pump in Rs12, 000cr of liquidity into the system by purchasing government bonds on October 11. This is mainlytoaidthemarketstomeetthefestivedemandfor funds. ! DrReddy’slaunchesthegenericwhile AlkemgetfinalUSFDAapproval Dr. Reddy’ Lab has said that the company has launched ColesevelamHCLtabletintheUSmarket.AspertheUSFDA drug database, Alkem Lab has also received final USFDA approvalforColesevelamHCLtablet.TheColesevelamHCL tabletissoldunderthebrandWelcholbyDaiichiSankyo Inc.ColesevelamHCLisanon-absorbed,polymeric,lipid- lowering and glucose lowering agent intended for oral administration.GlenmarklaunchedthisdruginMay2018 whileinthesamemonthSunPharmaalsolaunchedAGof thisdrug. ! SBI:CanbuyuptoRs30,000crmoreofNBFC loans StateBankofIndia,thecountry’slargestlender,hasextendedits supporttothebeleaguerednon-banklenders.Initially,thebank hadplannedforagrowthofRs15,000crthroughportfolio purchase.Now,ithasenhanceditstargettodoubletheprevious amount. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services: Intraday stock tips Financial advisory company Share market company * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

  7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

More Related